Clinical Trial Update: Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 study update investigating dose reduction of etanercept in patients with Ankylosing Spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Zhixiang Huang | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN